Navigation Links
FDA Advisory Committee Recommends Approval of REMICADE® for Treatment of Pediatric Ulcerative Colitis
Date:7/21/2011

health and medical care with their doctor.

Patients should let their doctors know if they have or ever had any of the following:

  • Tuberculosis (TB) or have been near someone who has TB. Your doctor will check you for TB with a skin test.  If you have latent (inactive) TB, you will begin TB treatment before you start REMICADE®.
  • Lived in a region where certain fungal infections like histoplasmosis or coccidioidomycosis are common.
  • Infections that keep coming back, have diabetes or an immune system problem.
  • Any type of cancer or a risk factor for developing cancer, for example, chronic obstructive pulmonary disease (COPD) or had phototherapy for psoriasis.
  • Heart failure or any heart condition.  Many people with heart failure should not take REMICADE®.
  • Hepatitis B virus (HBV) infection or think you may be a carrier of HBV.
  • Nervous system disorders (like multiple sclerosis or Guillain-Barre syndrome).
  • Also tell your doctor about any medications you are taking, including vaccines or Kineret (anakinra), Orencia (abatacept) and Actemra (tocilizumab) and if you are pregnant, plan to become pregnant or are nursing.  Adults and children should not receive a live vaccine while taking REMICADE®.

The following serious (sometimes fatal) side effects have been reported in people taking REMICADE®.

Patients should tell their doctors right away if you have any of the signs listed below:

  • Infections (like TB, blood infections, pneumonia) — fever, tiredness, cough, flu, or warm, red or painful skin or any open sores.  REMICADE® can make you more likely to get an infection or make any infection that you have worse.
  • Lymphoma, or any other cancers in adults and children.  
  • Heart failure — new or worsening symptoms, such as shortness of br
    '/>"/>

SOURCE Janssen Biotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
2. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
3. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
4. Schiffrin Barroway Topaz & Kessler, LLP and Janet Jenner & Suggs, LLC Comment on Conagra Advisory Regarding Pot Pies Linked to Salmonella Outbreak
5. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
6. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
7. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
8. FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
9. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
10. UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials
11. FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 2015  BC Technical, the nation,s leading non-OEM ... Systems, a Nuclear Imaging service company providing systems, ... their ongoing vision to provide the best, and ... Technical continues to expand their reach and expertise. ... valuable resources and knowledge in addition to strengthening ...
(Date:3/2/2015)... Calif., March 2, 2015  DURECT Corporation (Nasdaq: ... three months ended December 31, 2014. Total revenues were ... 2014 and for the three months ended December 31, ... months ended December 31, 2014 as compared to a ... in 2013.Total revenues were $19.4 million and net loss ...
(Date:3/2/2015)... -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) today reported ... December 31, 2014. Financial highlights for the fourth quarter include ... million, or $0.04 per share. This compares to revenues of ... $0.19 per share, for the fourth quarter of 2013. Financial ... million and a net loss of $68.4 million, or $0.56 ...
Breaking Medicine Technology:BC Technical Acquires Eclipse Systems 2DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 2DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 3DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 4DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 5DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 6DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 7DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 8DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 9DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 10DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 11DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 12Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 2Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 3Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 4Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 5Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 6Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 7Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 8Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 9
... CHARLOTTE, N.C., July 25, 2011 A leading international ... patients to ask their dentists about the potential for ... and holders that fasten patients, protective bibs in place. ... Research by Dr. John Molinari, Director of Infection Control ...
... In a comparative pharmacokinetic (PK) study, Upsher-Smith ... topiramate in development for the management of epilepsy ... twice-daily immediate-release topiramate (Topamax®*) in its extent of ... demonstrated a slower absorption profile compared with Topamax®. ...
Cached Medicine Technology:Question Your Dentist About Potential for Cross-Contamination, Leading Infection-Control Scientist Tells Fox News 2PK Study Comparing Upsher-Smith's Extended-Release Topiramate Formulation (USL255) With Topamax® Published Online In Epilepsia 2PK Study Comparing Upsher-Smith's Extended-Release Topiramate Formulation (USL255) With Topamax® Published Online In Epilepsia 3
(Date:3/3/2015)... (PRWEB) March 03, 2015 Human ... that it’s offering a new master health insurance plan ... its clients with a group platform removing potential cost ... Master Health Plan has been in effect since January ... clients with much need medical cost savings. , The ...
(Date:3/3/2015)... March 03, 2015 The authors Tracey Webb ... care for the future is a good and healthy ... UK) the authors have a created an ingenious book that ... vegetarian & vegan meals. , “Crude Food” shows readers ... and allergies, mainly caused by over processed refined foods ...
(Date:3/3/2015)... March 03, 2015 AliCare Medical ... care management programs and a member of the ... of Julie O’Brien as President. O’Brien formerly served ... Officer. In her new role, she will continue ... aspects of AMM’s call center operations, including clinical ...
(Date:3/3/2015)... 03, 2015 Motion 5 ... Environment from Pixel Film Studios. , “inMotion3D Environment is ... into 360° viewing area inside Motion 5” said Christina ... the line between professional and amateur making this plugin ... turn their 2D HDRI images into 360° viewing area ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 ... user-friendly website that focuses on providing an interactive ... schools, and addiction treatment for clients ranging in ... interventions on the site have a wide variety ... spectrum disorders, severe learning disabilities, drug rehabilitation, failure ...
Breaking Medicine News(10 mins):Health News:HCBR Group Offers Master Healthcare Plan through Humana 2Health News:New book ‘Crude Food’ gives readers ingenious ways to create healthy meals 2Health News:New book ‘Crude Food’ gives readers ingenious ways to create healthy meals 3Health News:Julie O'Brien Named President of AliCare Medical Management 2Health News:Julie O'Brien Named President of AliCare Medical Management 3Health News:A New Plugin Entitled inMotion3D Environment Was Released Today from Pixel Film Studios Exclusively for Motion 5 2Health News:All Kinds of Therapy – New Website for Behavioral Health and Substance Abuse Treatment Launches Today 2
... ... 440 Series motorized and mobile medical procedure table that reduces possible healthcare personnel and patient ... (PRWEB) May 10, ... has released the following information about a new mobile procedure table for use ...
... ups risk for early death, and too much could signal illness, ... sleep less than six hours a night are 12 percent more ... to eight hours of slumber, a new study has found. , ... too much -- more than nine hours a night -- doesn,t ...
... ... of our team of Judges and Management Team, iCMG is happy ... Award competition! These international awards along with "John Zachman award for ... for significant achievements in the field of Enterprise and IT Architecture. ...
... Health grant will help University of Central Florida researchers ... by multiple sclerosis and other neurological disorders. Stephen ... and a member of UCF,s Hybrid Systems Laboratory, has ... million project. His team will study the breakdown of ...
... May 2010 Flavour is literally the spice of ... of the table would be unthinkable. Yet just this ... dementias, with patients developing abnormal eating behaviours including changes ... research has revealed evidence that these behaviours are linked ...
... ... Collection is now available at SleepHappens.com. , ... (PRWEB) May 10, 2010 -- Mattress Warehouse is proud to ... Dreamwell Collection is exclusive to Mattress Warehouse and features unique BeautyStyle aesthetics and BeautyFeel ...
Cached Medicine News:Health News:Innovative Motorized and Mobile Medical Procedure Table Developed By MTI, Inc. 2Health News:6 to 8 Hours of Shut-Eye Is Optimal for Health 2Health News:iCMG Architecture Awards for Truly Outstanding Enterprise and IT Excellence 2Health News:iCMG Architecture Awards for Truly Outstanding Enterprise and IT Excellence 3Health News:$1.9 million grant to help UCF find multiple sclerosis 'nerve-ana' 2Health News:Dementia takes away the meaning of flavors 2Health News:Mattress Warehouse Announces Its New Simmons Mattress Lineup 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: